Oct 29, 2026 08:00AM
Aug 6, 2026 05:55PM
Aug 6, 2026 04:01PM
Jul 30, 2026 04:01PM
May 7, 2026 04:24PM
May 7, 2026 04:01PM
Apr 21, 2026 07:30AM Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting
Mar 12, 2026 04:02PM
Mar 12, 2026 04:01PM
Mar 5, 2026 04:01PM
Nov 4, 2025 04:17PM
Nov 4, 2025 04:01PM
Oct 28, 2025 04:01PM
Aug 7, 2025 04:13PM Corvus Pharmaceuticals, Inc. (CRVS) Tops Q2 EPS by 3c
Aug 7, 2025 04:01PM
Jul 31, 2025 04:01PM
May 8, 2025 04:03PM
May 8, 2025 04:02PM
Apr 23, 2025 04:08PM
Mar 26, 2025 06:49AM
Mar 25, 2025 04:01PM Corvus Pharmaceuticals, Inc. (CRVS) Misses Q4 EPS by 6c
Mar 25, 2025 04:01PM
Mar 17, 2025 04:01PM
Nov 12, 2024 04:03PM
Nov 12, 2024 04:01PM
Nov 5, 2024 04:02PM
Aug 16, 2024 02:59PM
Aug 6, 2024 04:05PM Corvus Pharmaceuticals, Inc. (CRVS) Tops Q2 EPS by 5c
Aug 6, 2024 04:01PM
Jul 31, 2024 08:30AM
May 6, 2024 04:11PM
May 6, 2024 04:01PM
May 2, 2024 04:02PM
Mar 19, 2024 04:09PM
Mar 19, 2024 04:02PM Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Mar 13, 2024 04:02PM
Nov 7, 2023 04:15PM
Nov 7, 2023 04:01PM
Oct 31, 2023 04:02PM
Aug 8, 2023 04:05PM
Aug 8, 2023 04:01PM
Aug 1, 2023 08:30AM Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter Financial Results on August 8, 2023
May 8, 2023 04:05PM
May 8, 2023 04:01PM
Apr 20, 2023 09:00AM
Mar 28, 2023 04:04PM
Mar 28, 2023 04:02PM
Mar 21, 2023 04:05PM
Nov 3, 2022 04:33PM Corvus Pharmaceuticals, Inc. (CRVS) Tops Q3 EPS by 47c
Nov 3, 2022 04:05PM

1,237,330 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All